A small device implanted just beneath the skin, roughly the size of a large postage stamp and weighing about two grams, kept ...

Irvine-based biotech company Eledon Pharmaceutical announced updated data from its islet cell transplant study.

An investigational antibody could reduce the toxicity associated with immune suppression in islet cell transplantation for type 1 diabetes (T1D), according to new preliminary data. Six people with T1D ...

For Dr. Daniel Gilada, a husband, physician and soon-to-be father of four, living with Type 1 diabetes had become “overwhelming.” “I felt so bad that it was becoming my new norm,” said Gilada, ...

Scientists have cured type 1 diabetes in mice, without long-term immune suppression. In type 1 diabetes, the immune system ...

For patients with brittle Type 1 diabetes, low blood sugar can be fatal. But CellTrans, spun out of decades of UI Health research, has developed an FDA-approved therapy to transplant insulin-producing ...

Islet Transplantation with Blood Vessel Cells Shows Promise to Treat Type 1 Diabetes Adding engineered human blood vessel-forming cells to islet transplants boosted the survival of the ...

Most diabetes patients must carefully monitor their blood sugar levels and inject insulin multiple times per day, to help ...

First-in-Human Study Provides Evidence that Sana’s Hypoimmune (HIP) Technology Enables Transplanted Islet Cells to Avoid Immune Rejection and Produce Insulin Without Immunosuppression Results ...

UI Health doctors performed a historic "first" in diabetes care last week when they transplanted islet cells into a patient — and got an insurer to say they'd cover it. The Chicago teaching hospital ...

Organ and cell transplants are potentially life-saving treatments for a variety of medical conditions, but their success depends on how long the transplanted cells or tissues can survive in their new ...